Posaconazole as first line treatment for disseminated zygomycosis

Mycoses. 2008 Nov;51(6):542-5. doi: 10.1111/j.1439-0507.2008.01499.x. Epub 2008 Apr 16.

Abstract

We describe the first case report of posaconazole use as first line agent in the treatment of disseminated zygomycosis with prosthetic hip joint and pulmonary involvement due to Rhizopus microsporus. This infection occurred in a heavily immunosuppressed patient with systemic lupus erythematosus.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antifungal Agents / therapeutic use*
  • Female
  • Hip Prosthesis
  • Humans
  • Immunocompromised Host
  • Lung Diseases, Fungal / drug therapy
  • Lupus Erythematosus, Systemic / complications
  • Middle Aged
  • Prosthesis-Related Infections / drug therapy
  • Rhizopus / isolation & purification*
  • Triazoles / therapeutic use*
  • Zygomycosis / drug therapy*

Substances

  • Antifungal Agents
  • Triazoles
  • posaconazole